CEACAM6: A Novel Marker of Chronic Obstructive Pulmonary Disease Susceptibility?

Am J Respir Crit Care Med. 2023 Jun 15;207(12):1546-1548. doi: 10.1164/rccm.202303-0610ED.

Authors

Alexandra C Racanelli¹, Augustine M K Choi¹

Affiliation

¹ Division of Pulmonary and Critical Care Medicine, Joan and Sanford I Weill Department of Medicine, Weill Cornell Medicine New York, New York, USA and New York Presbyterian Hospital-Weill Cornell Medical Center New York, New York, USA.

No abstract available

Publication types

Editorial
Research Support, N.I.H., Extramural
Comment

MeSH terms

Antigens, CD
Antioxidants*
Cell Adhesion Molecules
GPI-Linked Proteins
Humans
Pulmonary Disease, Chronic Obstructive* / diagnosis

Substances

Antioxidants
CEACAM6 protein, human
Antigens, CD
Cell Adhesion Molecules
GPI-Linked Proteins

Grants and funding